.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Baxter
Cantor Fitzgerald
Novartis
Boehringer Ingelheim
Daiichi Sankyo
Federal Trade Commission
McKinsey
Covington
Teva

Generated: January 19, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 0403247

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Astrazeneca PharmsEPANOVAomega-3-carboxylic acidsCAPSULE;ORAL205060-001May 5, 2014RXYesYes➤ Subscribe➤ SubscribeYTREATMENT OF HYPERTRIGLYCERIDEMIA
Astrazeneca PharmsEPANOVAomega-3-carboxylic acidsCAPSULE;ORAL205060-001May 5, 2014RXYesYes➤ Subscribe➤ SubscribeYTREATMENT OF HYPERTRIGLYCERIDEMIA
Astrazeneca PharmsEPANOVAomega-3-carboxylic acidsCAPSULE;ORAL205060-001May 5, 2014RXYesYes➤ Subscribe➤ SubscribeYTREATMENT OF HYPERTRIGLYCERIDEMIA
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist